Previous close | 2.1000 |
Open | 2.5000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 25.00 |
Expiry date | 2024-09-20 |
Day's range | 2.1000 - 2.5000 |
Contract range | N/A |
Volume | |
Open interest | 147 |
There hasn't been a new COPD treatment in years. But Regeneron stock analysts are closely watching a pair of key FDA decisions.
Insights into Verona Pharma's First Quarter Performance and Future Prospects
Verona Pharma plc (NASDAQ:VRNA) Q1 2024 Earnings Call Transcript May 9, 2024 Verona Pharma plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to Verona Pharma’s First Quarter 2024 Financial Results and Operating Highlights Conference Call. At […]